Related Experiment Video
Updated: Sep 15, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Autoimmune Pericarditis: Diagnosis and New Therapeutics
Heba Wassif1, Elizabeth Ghandakly2, Habib Layoun2
1Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. wassifh@ccf.org.
Autoimmune pericarditis diagnosis and treatment are reviewed. Interleukin-1 (IL-1) inhibition shows promise for specific subtypes, with future phenotyping guiding personalized therapy for this rare condition.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Autoimmune pericarditis is a rare condition with limited data.
- Its clinical presentation, severity, and recurrence vary widely.
- Pathophysiology distinguishes it from other pericarditis types.
Purpose of the Study:
- To review the current diagnostic strategies for autoimmune pericarditis.
- To outline updated therapeutic approaches for autoimmune pericarditis.
- To highlight the potential of IL-1 inhibition and future phenotyping.
Main Methods:
- Literature review of autoimmune pericarditis.
- Analysis of diagnostic criteria and clinical presentation.
- Evaluation of current and emerging therapeutic options.
Main Results:
- Autoimmune pericarditis presents with diverse clinical features.
- Interleukin-1 (IL-1) inhibition is a potential therapeutic avenue.
- Future phenotyping may personalize treatment strategies.
Conclusions:
- Accurate diagnosis and tailored therapy are crucial for autoimmune pericarditis.
- IL-1 inhibition offers a promising treatment option for specific subtypes.
- Further research into phenotyping will refine management approaches.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Myocarditis III: Medical Management
Pericarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests

